Author Archive

Combination therapy doubles survival in mice with mesothelioma

21 May 2018 by under Research/Treatment

research test tubes 100x100 Combination therapy doubles survival in mice with mesotheliomaCombining two cancer immunotherapy drugs – a novel immune modulator and a therapy that activates the anti-tumor immune response – more than doubled survival in laboratory mice with malignant mesothelioma, according to a report published in Cancer Immunology Research. (more…)


J&J to keep talc in its baby products despite asbestos concerns

18 May 2018 by under News

640px Talc mutnikSVK01 100x100 J&J to keep talc in its baby products despite asbestos concerns’s consumer health care division is relaunching its line of baby care products, removing concerning ingredients like dyes and sulfates and replacing mineral oil with coconut oil in an effort to appeal to ingredient-conscious millennial moms. But it isn’t touching the talc in its Johnson’s Baby Powder. In fact, the company is adding a new talc-containing product – one that combines talc with cotton. (more…)


Supreme Court to hear appeal of asbestos exposure case

16 May 2018 by under Legal

Lady justice Dublin L 100x100 Supreme Court to hear appeal of asbestos exposure caseThe U.S. Supreme Court will hear the appeal of a Third Circuit decision in two consolidated lawsuits that held companies accountable under maritime law for -related injuries if the companies could have reasonably known that was added to their products by third parties, according to Law360. (more…)


Immunotherapy an option for patients with recurrent pleural mesothelioma

14 May 2018 by under Research/Treatment

Diagram showing a build up of fluid in the lining of the lungs pleural effusion CRUK 0541 100x100 Immunotherapy an option for patients with recurrent pleural mesotheliomaA French study has found that immunotherapy may be effective in treating people with malignant pleural mesothelioma (MPM) that has recurred after standard chemotherapy. The treatment involved the use of two immunotherapy treatment plans – nivolumab (Opdivo) or a combination of nivolumab and ipilimumab (Yervoy). (more…)


Annual ADAO conference works to eradicate asbestos exposure

11 May 2018 by under Events

adao logo Annual ADAO conference works to eradicate asbestos exposureThe Asbestos Disease Awareness Organization (ADAO) held its 14th annual conference last month bringing together experts, survivors, unions and lawmakers from around the world to connect and share the latest education, advocacy and community support efforts.

The 2018 conference featured 30 experts from nine countries, and is the only annual conference dedicated solely to preventing exposure and eliminating -causing diseases. Attendees had the opportunity to connect with leaders and influencers in the prevention community, as well as victims of exposure and family members. (more…)


Study to examine experimental drug in patients with pleural mesothelioma

9 May 2018 by under Research/Treatment

research test tubes 100x100 Study to examine experimental drug in patients with pleural mesotheliomaMemorial is conducting a study to determine if adding an investigational drug to standard-of-care chemotherapy is more effective at extending lifespan in patients with malignant pleural mesothelioma.

The randomized, double-blind, phase II/III study, called POLAIS2015-003, is recruiting patients with malignant pleural with low argininosuccinate synthetase I expression. Aginine is a nutrient that makes up proteins. Laboratory studies show that ADI-PEG 20 can break down arginine, which can destroy cancer cells. Researchers want to determine if combining this experimental drug with stand-of-care chemotherapies is better than chemotherapy alone. (more…)


Experimental mesothelioma vaccine posts promising results

7 May 2018 by under Research/Treatment

syringe vaccine 100x100 Experimental mesothelioma vaccine posts promising resultsBiotech company reported positive results from a limited, Phase I/II clinical study involving its oncolytic virus platform ONCOS-102 and standard-of-care chemotherapy (pemetrexed/cisplatin) in patients with unresectable malignant pleural mesothelioma. After six months, tumor sizes were successfully reduced in three out of six patients treated with the experimental therapy. One patient had a partial response, and the disease was stable in the remaining two patients. (more…)


New guidelines support chemotherapy as first-line treatment for pleural mesothelioma

4 May 2018 by under Research/Treatment

No new drugs have been approved fDiagram showing a build up of fluid in the lining of the lungs pleural effusion CRUK 0541 100x100 New guidelines support chemotherapy as first line treatment for pleural mesotheliomaor the treatment of malignant pleural mesothelioma (MPM) since 2004, but there have been significant advances in recent years in understanding the biology of the disease and identifying new targets for therapy, the American Society of Clinical Oncology (ASCO) announced. (more…)


J&J, Imerys fight $117 million talc verdict

2 May 2018 by under Legal

640px Talc mutnikSVK01 100x100 J&J, Imerys fight $117 million talc verdict and its talc supplier Inc., pressed a New Jersey state court to toss a multi-million-dollar verdict the companies had been slapped with in a case of a man who claimed their talcum powder products contained asbestos and caused the man’s mesothelioma. (more…)


Asbestosis a serious complication from asbestos exposure

27 Apr 2018 by under News

800px Bauer Elementary ASBESTOS 2 100x100 Asbestosis a serious complication from asbestos exposure

Asbestosis is a serious, progressive, chronic lung disease caused by the scarring of lung tissue due to asbestos exposure. Most people become exposed to in work environments that are contaminated with , a fibrous mineral that has been linked to other serious diseases including mesothelioma and other cancers. (more…)